共 5 条
- [2] Screening for chronic kidney disease: Where does Europe go? [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (02): : 616 - 623
- [3] Cost-effectiveness of early irbesartan treatment versus control (standard antihypertension medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease [J]. DIABETES CARE, 2004, 27 (08) : 1897 - 1903